IP Library Granted Patent US 7,488,738
Granted Patent B2
US 7,488,738 · App. 11/174,575 · Granted Feb 10, 2009

Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,488,738
App. No.
11/174,575
Granted
Feb 10, 2009
Kind
B2
Abstract

There is provided an aminophenoxyacetic acid derivative of the following formula (I): wherein, R 1 , R 2 , R 3 and R 4 are, independent from each other, alkoxy group, alkyl group or aryl group, etc.; E 1 and E 2 are oxygen atom, sulfur atom, etc.; n is 0 to 5; X and Y are alkylene group, cycloalkylen group, or alkenylen group; Q is phenyl group which may be substituted or benzoyl group, etc, or a pharmaceutically acceptable salt thereof. These compounds have neuroprotective effects by inducing calbindin D28Kd, one of Ca 2+ -binding proteins.

Claims (6)

1. A composition comprising a compound which is 4-({4-[[(4-Amino-2,3,5,6-tetramethylanilino)acetyl]-(methyl)amino]-1-piperidino}methyl)benzamide or a pharmaceutically acceptable salt thereof, in an amount effective for improving brain cell survival or suppressing cerebral edema, and a pharmaceutically acceptable carrier therefor.

2. A composition comprising a compound which is 2-(4-Amino-2,3,5,6-tetramethylanilino)-N-[1-(cyclo-propylmethyl) -4-piperidinyl]-N-methylpropamide or a pharmaceutically acceptable salt thereof, in an amount effective for improving brain cell survival or suppressing cerebral edema, and a pharmaceutically acceptable carrier therefor.

3. A composition comprising a compound which is 2-(4-Amino-2,3,5,6-tetramethylanilino)-N-methyl-[1-(2-phenyl-2-oxyethyl) -4-piperidinyl]acetamide or a pharmaceutically acceptable salt thereof in an amount effective for improving brain cell survival or suppressing cerebral, and a pharmaceutically acceptable carrier therefor.

4. A composition comprising a compound which is 2-(4-Amino-2,3,5,6-tetramethylanilino)-N-[1-[1-(2-hydroxy-2-phenylethyl) -4-piperidinyl]-N-methylacetamide or a pharmaceutically acceptable salt thereof, in an amount effective for improving brain cell survival or suppressing cerebral, and a pharmaceutically acceptable carrier therefor.

5. A composition comprising a compound which is 2-(4-Amino-2,5-dichloroanilino)-N-[1-(2-phenethyl)-4-piperidinyl]acetamide or a pharmaceutically acceptable salt thereof, in an amount effective for improving brain cell survival or suppressing cerebral, and a pharmaceutically acceptable carrier therefor.

6. A composition comprising a compound which is 2-(3-Amino-2,4,6-trimethylanilino)-N-(1-benzoyl-4-piperidinyl)-N-methylacetamide or a pharmaceutically acceptable salt thereof.

Assignments (2)
CHANGE OF NAME Recorded Jun 5, 2007
From: DAIICHI ASUBIO PHARMA CO., LTD.
To: ASUBIO PHARMA CO., LTD.
Reel/Frame 019553/0940 →
CHANGE OF NAME Recorded Dec 21, 2005
From: DAIICHI SUNTORY PHARMA CO., LTD.
To: DAIICHI ASUBIO PHARMA CO., LTD.
Reel/Frame 017384/0476 →